CancerNCT02829554
Differential Influences of Integral and Incidental Emotion on Cancer-related Judgments and Decision Making
An observational study of Cancer and Overweight, run by National Cancer Institute (NCI) at 1 site in United States.
Trial summary
Background: Researchers are testing new methods for research projects. They want to see how people respond to different types of communication, including videos. They also want to learn how people respond to life events and how they pay attention to computer tasks. Read more about this study
- Who is it for?
- Ages 18 to 99 years
- Conditions the study is for
- Cancer, Overweight, Obesity
- How many people
- 6,242 participants
- Where
- 1 siteUnited States
- Study dates
- 8 Jul 2016to 15 May 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 99 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Studies 1a-3: general sample, nominally healthy individuals, recruited via Amazon mTurk, US residents only (age 18+) Study 2: three types of samples: 1) general sample, nominally healthy individuals, recruited via Amazon mTurk, US residents only (age 18+); 2) individuals who have been diagnosed with cancer (cancer survivors); 3) individuals who have low self-reported health
Who may be able to join
- Adults ages 18 and older with a U.S. computer address
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
United States1 site
National Cancer Institute (NCI)
Bethesda, Maryland, 20892
About this study
Official title: Differential Influences of Integral and Incidental Emotion on Cancer-Related Judgments and Decision Making
Background:
Researchers are testing new methods for research projects. They want to see how people respond to different types of communication, including videos. They also want to learn how people respond to life events and how they pay attention to computer tasks. They want to learn about how various risks and threats affect the way people make decisions.
Read more
Objectives:
To learn how different stimuli and events affect the way people make decisions.
Eligibility:
Adults ages 18 and older with a U.S. computer address
Design:
Participants will be recruited online.
Participants will take one of three studies online. Each study will take about a half hour.
Participants in Study 1 will watch a short video from a popular movie then answer questions. They will also complete 2 questionnaires. One will be about how likely they think it is that they will experience different risks and threats. The other will be about goals for behavior change.
Participants in Study 2 will write in detail about a life event. Then they will answer questions. They will also complete the same 2 questionnaires as Study 1.
Participants in Study 3 will pay close attention to words and images on a computer. They will answer questions about attitudes toward different behaviors, products, and experiences.
...
Read the detailed description
Despite evidence that both integral (i.e., related to the decision) and incidental (i.e., unrelated to the decision) emotions influence cancer-related decision making, no research has systematically examined whether these two types of emotion generate similar patterns of influence, as predicted by decision-making models. This is important because incidental emotions are often used experimentally to draw causal conclusions about how emotions influence cancer-related decisions with the notion that results will generalize to produce knowledge about integral emotions as well. Across three studies, we plan to directly compare integral and incidental emotional influences on judgments and decisions related to cancer control. We plan to examine whether effects are contingent on the type of emotional influence (the discrete emotions anger and fear, or general positive affect) or type of emotion induction (video, autobiographical induction, or evaluative conditioning). Across experiments, we predict that emotion will influence both judgment and decision-making outcomes when the induced emotion is integral as well as when it is incidental. However, we predict that the magnitude of the effect of emotion on these types of responses will be significantly greater when emotions are integral to a judgment or decision, compared to when emotions are incidental.
- Conditions
- Cancer, Overweight, Obesity
- Keywords
- Emotion, Judgment, Decision Making
- Medical subject headings
- Neoplasms, Overweight, Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Respondents | US residents recruited to an on-line questionnaire through Amazon mTurk. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Risk perceptions
Perceived susceptibility to cancer and other threats (self-report)
Measured: End of protocol
Intentions
Intentions to engage in cancer and other threat-preventive behavior (self-report)
Measured: End of protocol
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Jul 2016 (estimated)
- Study start8 Jul 2016
- Primary completion29 Aug 2016
- Study completion15 May 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CancerStudies of the same condition, open and under way.
- More trials run by National Cancer Institute (NCI)The sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 6,242 participants (actual)
Sponsor and investigators
- Lead sponsor
- National Cancer Institute (NCI)
- Sponsor type
- US National Institutes of Health
- Responsible party
- Sponsor
- Investigators
- Rebecca A Ferrer, Ph.D., Principal investigator, National Cancer Institute (NCI)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02829554
- Sponsor's protocol ID
- 999916142
- Other IDs
- 16-C-N142
- Status last verified
- May 2020
- First submitted
- 8 Jul 2016
- Last updated
- 20 May 2020
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 May 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Differential Influences of Integral and Incidental Emotion on Cancer-Related Judgments and Decision Making
- ClinicalTrials.gov ID
- NCT02829554
- Acronym / sponsor ID
- 999916142
- Conditions
- Cancer, Overweight, Obesity
- Keywords
- Emotion, Judgment, Decision Making
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 6,242 participants (actual)
- Lead sponsor
- National Cancer Institute (NCI)US National Institutes of Health
- Study start
- 8 Jul 2016 (actual)
- Primary completion
- 29 Aug 2016 (actual)
- Study completion
- 15 May 2020 (actual)
- First posted
- 12 Jul 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background:
Researchers are testing new methods for research projects. They want to see how people respond to different types of communication, including videos. They also want to learn how people respond to life events and how they pay attention to computer tasks. They want to learn about how various risks and threats affect the way people make decisions.
Objectives:
To learn how different stimuli and events affect the way people make decisions.
Eligibility:
Adults ages 18 and older with a U.S. computer address
Design:
Participants will be recruited online.
Participants will take one of three studies online. Each study will take about a half hour.
Participants in Study 1 will watch a short video from a popular movie then answer questions. They will also complete 2 questionnaires. One will be about how likely they think it is that they will experience different risks and threats. The other will be about goals for behavior change.
Participants in Study 2 will write in detail about a life event. Then they will answer questions. They will also complete the same 2 questionnaires as Study 1.
Participants in Study 3 will pay close attention to words and images on a computer. They will answer questions about attitudes toward different behaviors, products, and experiences.
...
Detailed description
Despite evidence that both integral (i.e., related to the decision) and incidental (i.e., unrelated to the decision) emotions influence cancer-related decision making, no research has systematically examined whether these two types of emotion generate similar patterns of influence, as predicted by decision-making models. This is important because incidental emotions are often used experimentally to draw causal conclusions about how emotions influence cancer-related decisions with the notion that results will generalize to produce knowledge about integral emotions as well. Across three studies, we plan to directly compare integral and incidental emotional influences on judgments and decisions related to cancer control. We plan to examine whether effects are contingent on the type of emotional influence (the discrete emotions anger and fear, or general positive affect) or type of emotion induction (video, autobiographical induction, or evaluative conditioning). Across experiments, we predict that emotion will influence both judgment and decision-making outcomes when the induced emotion is integral as well as when it is incidental. However, we predict that the magnitude of the effect of emotion on these types of responses will be significantly greater when emotions are integral to a judgment or decision, compared to when emotions are incidental.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Respondents | – | –US residents recruited to an on-line questionnaire through Amazon mTurk. |
Who may qualify
- Ages
- 18 to 99 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Studies 1a-3: general sample, nominally healthy individuals, recruited via Amazon mTurk, US residents only (age 18+) Study 2: three types of samples: 1) general sample, nominally healthy individuals, recruited via Amazon mTurk, US residents only (age 18+); 2) individuals who have been diagnosed with cancer (cancer survivors); 3) individuals who have low self-reported health
Key inclusion criteria (1 listed)
- Adults ages 18 and older with a U.S. computer address
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Risk perceptions
Time frame: End of protocol
Perceived susceptibility to cancer and other threats (self-report)
Intentions
Time frame: End of protocol
Intentions to engage in cancer and other threat-preventive behavior (self-report)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 May 2020.
Related trials for Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Rebecca A Ferrer, Ph.D. principal investigator
National Cancer Institute (NCI)
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cancer and Overweight, run by National Cancer Institute (NCI) at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 May 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Risk perceptions (time frame: End of protocol). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2020; AzTrials last refreshed its copy on 8 Nov 2026.